Cannabinoids for symptom management in children with cancer: It’s complicated

Data surrounding the use of cannabinoids for symptom management in children with cancer are heterogeneous and extremely limited. Well‐designed clinical trials with specific indications, products, and outcome metrics are required before cannabinoids should be considered in frontline cancer care in ch...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2023-11, Vol.129 (22), p.3522-3524
Hauptverfasser:	Spraker‐Perlman, Holly L., Heidelberg, R. Elyse
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Cannabinoids Children Clinical trials Symptom management
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Data surrounding the use of cannabinoids for symptom management in children with cancer are heterogeneous and extremely limited. Well‐designed clinical trials with specific indications, products, and outcome metrics are required before cannabinoids should be considered in frontline cancer care in children.
ISSN:	0008-543X 1097-0142
DOI:	10.1002/cncr.34962